A glance into the future of diagnosis and treatment of spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35898564/

Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs (2022)
https://pubmed.ncbi.nlm.nih.gov/35046098/

The impact of genetic background and sex on the phenotype of IL-23 induced murine spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33983951/

Recognizing Axial Spondyloarthritis: A Guide for Primary Care (2020)
https://pubmed.ncbi.nlm.nih.gov/32736944/

Spondyloarthritis evolution: what is in your history? (2020)
https://pubmed.ncbi.nlm.nih.gov/32453039/

Pathogenesis of Axial Spondyloarthritis – Sources and Current State of Knowledge (2020)
https://pubmed.ncbi.nlm.nih.gov/32340695/

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W) (2020)
https://pubmed.ncbi.nlm.nih.gov/31685553/

Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records (2020)
https://pubmed.ncbi.nlm.nih.gov/31535693/

Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States (2019)
https://pubmed.ncbi.nlm.nih.gov/31081033/